Prognostic value of neutrophil-to-lymphocyte ratio in end-stage liver disease: A meta-analysis

Figure 1 PRISMA flowchart outlining the study search. NLR: Neutrophil-to-lymphocyte ratio; ESLD: End-stage liver disease.

Figure 2 Forest plot of association between neutrophil-to-lymphocyte ratio and end-stage liver disease mortality. A: Univariate hazard ratios (HR); B: Multivariate HR; C: Univariate odds ratios (OR); D: Multivariate OR. Different subgroup data extracted in the same literature were distinguished using the letter (^a) and (^b).